Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum

L-DOPA-induced dyskinesias (LID) remain a major problem of long-term therapy of Parkinson's disease. Levetiracetam, a new antiepileptic drug, has been shown to reduce LID, but the mechanisms underlying its effects are unknown. In this study, we assessed the effect of levetiracetam on key mediat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Parkinsons Dis
Huvudupphovsmän: Du, Huan, Nie, Shuke, Chen, Guiqin, Ma, Kai, Xu, Yan, Zhang, Zhentao, Papa, Stella M., Cao, Xuebing
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322303/
https://ncbi.nlm.nih.gov/pubmed/25692070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/253878
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk